Fit and well (finding)

Healthy Volunteer Collection

Year Started: 2018

Collection of samples from Healthy Volunteers alongside health questionnaire data



Access:
Open to applicants
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months
Survey data 0 - 3 months
Donor Ethnicity 0 - 3 months


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma Liquid nitrogen vapor phase Not applicable 51 - 75%
Saliva Liquid nitrogen vapor phase Not applicable 51 - 75%
Serum -60°C to -85°C Not applicable 11 - 25%
Serum Liquid nitrogen vapor phase Not applicable 26 - 50%
Whole blood Liquid nitrogen vapor phase Not applicable 51 - 75%
Plasma -60°C to -85°C Not applicable 0 - 10%
Whole blood -60°C to -85°C Not applicable 0 - 10%
Saliva -60°C to -85°C Not applicable 0 - 10%


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma Liquid nitrogen vapor phase Not applicable 11 - 25%
Saliva Liquid nitrogen vapor phase Not applicable 26 - 50%
Serum -60°C to -85°C Not applicable 0 - 10%
Whole blood Liquid nitrogen vapor phase Not applicable 11 - 25%
Plasma -60°C to -85°C Not applicable 0 - 10%
Whole blood -60°C to -85°C Not applicable 0 - 10%
Saliva -60°C to -85°C Not applicable 0 - 10%


Male

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma Liquid nitrogen vapor phase Not applicable 100%
Saliva Liquid nitrogen vapor phase Not applicable 75% -99%
Serum -60°C to -85°C Not applicable 26 - 50%
Serum Liquid nitrogen vapor phase Not applicable 26 - 50%
Whole blood Liquid nitrogen vapor phase Not applicable 100%


Male

Young adult (18 - 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma Liquid nitrogen vapor phase Not applicable 11 - 25%
Saliva Liquid nitrogen vapor phase Not applicable 75% -99%
Serum -60°C to -85°C Not applicable 26 - 50%
Whole blood Liquid nitrogen vapor phase Not applicable 26 - 50%

Cystic fibrosis (disorder)

Cystic Fibrosis Collection

Year Started: 2020



Access:
Open to applicants
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 100%
Whole blood -60°C to -85°C Not applicable 100%
Sputum -60°C to -85°C Not applicable 51 - 75%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 75% -99%
Whole blood -60°C to -85°C Not applicable 75% -99%
Sputum -60°C to -85°C Not applicable 51 - 75%


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 75% -99%
Whole blood -60°C to -85°C Not applicable 75% -99%
Sputum -60°C to -85°C Not applicable 26 - 50%


Male

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 100%
Whole blood -60°C to -85°C Not applicable 100%


Male

Young child (2 - 6 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Sputum -60°C to -85°C Not applicable 26 - 50%
Swab -60°C to -85°C Not applicable 51 - 75%


Male

Child (6 - 12 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Swab -60°C to -85°C Not applicable 100%


Female

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 100%
Whole blood -60°C to -85°C Not applicable 100%


Female

Young child (2 - 6 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Sputum -60°C to -85°C Not applicable 51 - 75%
Swab -60°C to -85°C Not applicable 100%


Male

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 75% -99%
Whole blood -60°C to -85°C Not applicable 75% -99%
Sputum -60°C to -85°C Not applicable 26 - 50%

Urinary tract infectious disease (disorder)

DUTY- Diagnosis of Urinary Tract infection in Young children

Year Started: 2010

The DUTY (Diagnosis of Urinary Tract infection in Young children) study was designed to improve the way in which doctors and nurses find out when a young child has a urine infection so that they can start effective treatment earlier.



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Commercial restriction, DNA restriction, Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Freezer temperature logs 0 - 3 months
Physiological/biochemical measurements 3 - 6 months
Survey data 3 - 6 months


Unknown

Neonate (0 - 1 month)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Urine -60°C to -85°C N/A Not applicable 100%


Unknown

Infant (1 month - 2 years)

3001 - 5000 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Urine -60°C to -85°C N/A Not applicable 100%


Unknown

Young child (2 - 6 years)

1001 - 3000 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Urine -60°C to -85°C N/A Not applicable 100%


Unknown

Data not recorded

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Urine -60°C to -85°C N/A Not applicable 100%

Neurofibromatosis, type 1 (disorder)

Neurofibromatosis Type 1 Collection

Year Started: 1990



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Unknown

Data not recorded

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) -60°C to -85°C N/A Not applicable 51 - 75%
Tissue specimen Surgical procedure (procedure) RT Paraffin Not applicable 26 - 50%

Acute myeloid leukemia, disease (disorder)

AML 10 Clinical Trial Collection

Year Started: 1992

Samples from the AML 10 Clinical Trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Female

Young adult (18 - 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 100%


Male

Young adult (18 - 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 100%


Male

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 100%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 100%

Acute myeloid leukemia, disease (disorder)

AML 11 Clinical Trial Collection

Year Started: 1992

Samples from the AML 11 Clinical Trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 26 - 50%
Primary cells Liquid nitrogen vapor phase Not applicable 51 - 75%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 26 - 50%
Primary cells Liquid nitrogen vapor phase Not applicable 51 - 75%

Acute myeloid leukemia, disease (disorder)

AML 12 Clinical Trial Collection

Year Started: 1995

Samples from the AML12 Clinical Trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 51 - 75%
Primary cells Liquid nitrogen vapor phase Not applicable 51 - 75%


Female

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 26 - 50%
Primary cells Liquid nitrogen vapor phase Not applicable 51 - 75%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 51 - 75%
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%


Male

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 51 - 75%
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 51 - 75%
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%

Acute myeloid leukemia, disease (disorder)

AML 14 Clinical Trial Collection

Year Started: 1999

Samples from the AML 14 clinical trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Unknown

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%
Primary cells Liquid nitrogen vapor phase Not applicable 11 - 25%


Male

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%

Acute myeloid leukemia, disease (disorder)

AML 15 Clinical Trial Collection

Year Started: 2002

Samples from the AML 15 Clinical Trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Followup records 3 - 6 months
Treatment records 3 - 6 months


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%
Primary cells Liquid nitrogen vapor phase Not applicable 11 - 25%


Male

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 51 - 75%
Primary cells Liquid nitrogen vapor phase Not applicable 51 - 75%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%
Primary cells Liquid nitrogen vapor phase Not applicable 11 - 25%


Male

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 100%

Acute myeloid leukemia, disease (disorder)

AML 16 Clinical Trial Collection

Year Started: 2006

Samples from the AML 16 trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Followup records 3 - 6 months
Treatment records 3 - 6 months


Female

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 11 - 25%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%


Male

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%

Diabetic foot ulcer (disorder)

INDUCE: Point-of-care tests to assist antibiotic prescribing decisions for diabetic foot ulcer infections

Year Started: 2014



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Commercial restriction, DNA restriction, Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Survey data 3 - 6 months
Treatment records 3 - 6 months


Unknown

Data not recorded

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 100%
Swab -60°C to -85°C Not applicable 75% -99%

Acute myeloid leukemia, disease (disorder)

AML 17 Clinical Trial Collection

Year Started: 2007

Samples from the AML 17 trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Followup records 3 - 6 months
Treatment records 3 - 6 months


Unknown

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 51 - 75%


Unknown

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%


Unknown

Adolescent (12 - 18 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 100%